104 related articles for article (PubMed ID: 7113740)
1. The dipyridamole-PCG-test, a pattern for noninvasive assessment of left ventricular function in coronary heart disease.
Huml D; Numíc N
Acta Med Iugosl; 1982; 36(2):77-99. PubMed ID: 7113740
[No Abstract] [Full Text] [Related]
2. [Systolic time intervals: indications and limitations in evaluation of left ventricular function].
Ferro G; Tari MG; Chiarello M
G Ital Cardiol; 1982; 12(1):83-8. PubMed ID: 7128996
[No Abstract] [Full Text] [Related]
3. [Evaluation of left ventricular function with the postural polygraphy test].
Dvorák I; Bravený P; Zemánková J; Stejfa M; Blaha M; Dvorák M; Sedá L; Havlát F
Vnitr Lek; 1981 Apr; 27(4):332-7. PubMed ID: 7293023
[No Abstract] [Full Text] [Related]
4. [Experience with the dipyridamole test in the diagnosis of ischemic coronary disease].
Chynoradská E; Hluchý J; Pavlovic M; Lipták O
Vnitr Lek; 1984 Jan; 30(1):31-7. PubMed ID: 6695514
[No Abstract] [Full Text] [Related]
5. Value of the noninvasive polygraphic tracing in patients with coronary heart disease.
Jandík J
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1982; 25(4-5):487-573. PubMed ID: 6985360
[No Abstract] [Full Text] [Related]
6. Prognostic value of dipyridamole stress echocardiography in hypertensive patients with left ventricular hypertrophy, chest pain and resting electrocardiographic repolarization abnormalities.
Mondillo S; Agricola E; Ammaturo T; Guerrini F; Barbati R; Focardi M; Picchi A; Ballo P; Nami R
Can J Cardiol; 2001 May; 17(5):571-7. PubMed ID: 11381279
[TBL] [Abstract][Full Text] [Related]
7. Polycardiographic analysis of a provocative dipyridamole test in coronary heart disease.
Markiewicz K; Cholewa M; Kaczorowski K; Gawor Z
Acta Med Pol; 1988; 29(3-4):151-65. PubMed ID: 3154288
[No Abstract] [Full Text] [Related]
8. [Evaluation of the usefulness of pharmacological dipyridamole test for the diagnosis of coronary insufficiency].
Halawa B; Mazurek W
Pol Tyg Lek; 1979 Jun; 34(23):901-2. PubMed ID: 482155
[No Abstract] [Full Text] [Related]
9. [Comparison of noninvasive and invasive indicators of left ventricular function in patients with ischemic heart disease].
Dvorák I; Bravený P; Blaha M; Spác J; Kubesová H; Zemánková J; Slavícek F; Nĕmcová H; Havlát F; Safránek I
Vnitr Lek; 1982 Dec; 28(12):1166-75. PubMed ID: 7157694
[No Abstract] [Full Text] [Related]
10. [Differences between women and men in the dipyridamole test. Symptomatic and electrocardiography findings in patients with coronary heart disease].
Grosse-Heitmeyer W; Huber T
Med Klin (Munich); 1994 May; 89(5):233-9. PubMed ID: 8052176
[TBL] [Abstract][Full Text] [Related]
11. Assessment of left ventricular function by noninvasive methods.
Luisada AA; Singhal A; Portaluppi F
Adv Cardiol; 1985; 32():111-41. PubMed ID: 4003144
[TBL] [Abstract][Full Text] [Related]
12. [Multislice TrueFISP-MR imaging for identifying stress-induced myocardial functional disturbances in coronary heart disease].
Kramer U; Fenchel M; Helber U; Kraft A; Stauder NI; Franow A; Claussen CD; Miller S
Rofo; 2003 Oct; 175(10):1355-62. PubMed ID: 14556104
[TBL] [Abstract][Full Text] [Related]
13. [What coronary findings predispose to premature termination of a strong positive dipyridamole test?].
Grosse-Heitmeyer W
Wien Med Wochenschr; 1993; 143(11):301-5. PubMed ID: 8212717
[TBL] [Abstract][Full Text] [Related]
14. [Letter: Dipyridamole test for the diagnosis of coronary insufficiency].
Tauchert M; Hilger HH; Strube R
Dtsch Med Wochenschr; 1976 Apr; 101(14):560. PubMed ID: 1261368
[No Abstract] [Full Text] [Related]
15. [Diagnosis of coronary artery disease by intravenous administration of dipyridamole].
Ikeda K; Kawashima S; Tsuiki K; Yasui S; Miyazawa K
Rinsho Byori; 1986 Oct; 34(10):1148-54. PubMed ID: 3806999
[No Abstract] [Full Text] [Related]
16. [Myocardial microcirculation in humans--new approaches using MRI].
Wacker CM; Bauer WR
Herz; 2003 Mar; 28(2):74-81. PubMed ID: 12669220
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty (PTCA) by intracoronary dipyridamole: hemodynamic, contractile and dynamic ventricular consequences].
Strauer BE; Heidland UE; Heintzen MP; Schwartzkopff B
Z Kardiol; 1995 Nov; 84(11):898-910. PubMed ID: 8571641
[TBL] [Abstract][Full Text] [Related]
18. [Functional evaluation of the myocardium by polygraphic examination in coronary sclerosis and in myocardial infarct].
Cardini G; Clemente R; Riggio G
Minerva Cardioangiol; 1966 Jan; 14(1):29-35. PubMed ID: 5908607
[No Abstract] [Full Text] [Related]
19. Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty by intracoronary application of dipyridamole: impact on hemodynamic function and left ventricular performance.
Strauer BE; Heidland UE; Heintzen MP; Schwartzkopff B
J Am Coll Cardiol; 1996 Nov; 28(5):1119-26. PubMed ID: 8890804
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive prediction of restenosis after coronary angioplasty: a head to head comparison among exercise ECG, dipyridamole and exercise thallium scintigraphy.
Casanova R; Varani E; Balducelli M; Patroncini A; Fabbri M; Maresta A
J Invasive Cardiol; 1994; 6(1):1-6. PubMed ID: 10146699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
